Study | Number | Median age (yr) (range) | Median FU (mo) | PWC sample available (n) | Malignant PWC (n) | Malignant PWC associated w/ ovarian/fallopian tube cancer (n) | Benign PWC associated w/ovarian/fallopian tube cancer (n) | Malignant PWC and PPC during RRSO | Malignant PWC and PPC in FU (n) | Malignant PWC not associated w/ovarian/fallopian tube cancer (n) | Median age women w/malignant PWC (yr) | Median FU women w/malignant PWC (mo) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Colgan et al. [12] | 35 | NA | NA | 35 | 3a | 2a | 1 | 0 | 0 | 1a | NA | NA |
Leunen et al. [14] | 51 | 45g | 25 | 28 | 0 | - | 0 | - | - | - | - | - |
Eitan et al. [13]b | 130 | 48 (33–78) | 20 | 117 | 0 | - | 0 | - | - | - | - | - |
Haldar et al. [1] | 113 | 52 (35–78) | 34 | 110 | 2 | 2c | 0 | 0c | 0c | 0 | NA | NA |
Landon et al. [15] | 116d | NA | NA | 116d | 0d | 0d | 9 | 0 | - | - | NA | NA |
Chen et al. [11] | 163 | NA | NA | 163 | 6 | 6 | 6 | 0 | 0e | 0 | NA | NA |
Present study Blok et al. | 471 | 48 | 56 | 267 | 4 | 4 | 7 | 0 | 0f | 0 | 47.6 (SD, 8.5) | 58 |
Total | 1079 | 836 | 15 | 14 | 23 | 0 | 0 | 1 |